Category: Pharmaceuticals - Page 3
How Multiple Generic Drug Competitors Affect Prices and Market Stability
Multiple generic drug competitors don't always lead to lower prices. Real-world factors like patent strategies, regulatory caps, and pharmacy benefit managers shape market outcomes - sometimes limiting competition despite many approved generics.
MoreCitalopram and Escitalopram: QT Prolongation Risks and Safe Dose Limits
Citalopram and escitalopram are effective antidepressants but carry QT prolongation risks that require strict dose limits. Learn the safe dosing guidelines, who’s at risk, and how to minimize cardiac complications.
MoreFirst-Generation Antihistamines: Why Severe Drowsiness and Anticholinergic Effects Matter
First-generation antihistamines like Benadryl cause severe drowsiness and anticholinergic side effects that can impair cognition, increase dementia risk, and linger for hours. Learn why they're risky-and what to use instead.
MoreMachine Learning Signal Detection: How AI Is Revolutionizing Adverse Event Monitoring
Machine learning signal detection is transforming pharmacovigilance by spotting hidden adverse drug reactions faster and more accurately than traditional methods. Using AI on real-world data, it's reducing false alarms and catching dangers before they escalate.
MoreBioequivalence Testing for Generic Drugs: What It Really Proves
Bioequivalence testing proves generic drugs work the same as brand-name versions by matching how quickly and how much of the active ingredient enters the bloodstream. It's the science behind affordable medicine.
MoreNitrosamine Contamination in Generic Drugs: Recent Recalls and Regulatory Shifts
Nitrosamine contamination in generic drugs has led to over 500 FDA recalls since 2018. Learn which medications were affected, why it happened, and how regulators and manufacturers are responding to protect patient safety.
MoreTamiflu vs Alternatives: What Works Best for Flu Treatment in 2025
Compare Tamiflu with modern flu antivirals like Xofluza, Relenza, and Rapivab in 2025. Learn which one works best for your age, health, and budget - and when you don’t need any at all.
MoreCozaar (Losartan) vs Alternatives: Which Blood Pressure Medication Is Right for You?
Cozaar (losartan) is a common blood pressure medication, but it's not right for everyone. Learn how it compares to alternatives like lisinopril, amlodipine, and HCTZ - and which one might work better for your body.
MoreArtificial Intelligence in Drug Safety: How Technology Detects Problems
Artificial intelligence is transforming drug safety by detecting hidden adverse reactions in real time using millions of data points. Learn how AI finds risks humans miss - and why experts say it’s changing pharmacovigilance forever.
MoreCopegus (Ribavirin) vs. Alternatives: What Works Best for Hepatitis C Today
Copegus (ribavirin) is outdated for hepatitis C treatment. Modern direct acting antivirals like Harvoni and Epclusa cure over 95% of cases in 8-12 weeks with minimal side effects. Learn why ribavirin is rarely used today and what alternatives work better.
More